Matthew R Patterson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew R Patterson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew R Patterson. Matthew R Patterson is a Acting CEO & President in AMICUS THERAPEUTICS INC ($FOLD) and a Chief Operating Officer in AMICUS THERAPEUTICS INC ($FOLD) and an Chief Executive Officer in Audentes Therapeutics, Inc. ($BOLD) and a President & CEO in Audentes Therapeutics, Inc. ($BOLD) and a Director in Homology Medicines, Inc. ($FIXX) and a Director in Vor Biopharma Inc. ($VOR) and a Director in 5:01 Acquisition Corp. ($FVAM).
Address: C/O AMICUS THERAPEUTICS, INC. 6 CEDAR BROOK DRIVE CRANBURY 08512 NJ
Companies in which Matthew R Patterson is an Insider
5:01 Acquisition Corp.
Industry: BLANK CHECKS [6770]
Position of Matthew R Patterson: Director
Holdings: 0 shares
Latest Transaction: Oct 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AMICUS THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew R Patterson: Acting CEO & President, Chief Operating Officer
Holdings: 106,547 shares
Current Value: $641,413
Latest Transaction: Apr 19 2011
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew R Patterson: Chief Executive Officer, President & CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 15 2020
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Homology Medicines, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew R Patterson: Director
Holdings: 0 shares
Latest Transaction: Jun 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vor Biopharma Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew R Patterson: Director
Holdings: 0 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew R Patterson
Sentiment: All, FVAM, FOLD, BOLD, FIXX, VOR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 7.26 | 18,000 | 130,680 | 18,000 | |
| Feb 09 2021 | VOR | Vor Biopharma Inc. | Patterson Matthew R | Director | Option Exercise | A | 18.00 | 16,900 | 304,200 | 16,900 | |
| Oct 20 2020 | FVAM | 5:01 Acquisition C ... | Patterson Matthew R | Director | Option Exercise | J | 0.00 | 30,000 | 0 | 30,000 | |
| Oct 20 2020 | FVAM | 5:01 Acquisition C ... | Patterson Matthew R | Director | Option Exercise | J | 0.00 | 30,000 | 0 | 30,000 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | D | 24.74 | 177,450 | 4,390,113 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | D | 27.39 | 225,000 | 6,162,750 | 0 |